Close Menu

NEW YORK (GenomeWeb) – Computational biology startup Camp4 Therapeutics has emerged from stealth mode and closed on a $30 million Series A round of venture capital.

Andreessen Horowitz led the round, with participation from Polaris Partners and the Kraft Group. Polaris Partners supported an earlier seed round, according to Cambridge, Massachusetts-based Camp4.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.